The other factor that the industry is watching out for is the imposition of tariffs on drug imports in to the US, on which ...

On Sunday, secretary of the treasury Scott Bessent revealed that there had been 'substantial progress between the United ...

Warren Buffett surprised investors at Berkshire Hathaway's annual meeting, announcing that he will step down as CEO at the ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

The richest sliver of Americans now own a record share of the wealth, and tweaking income taxes is unlikely to change that.

The US and China both pointed to progress after high-stakes trade talks over the weekend, with both sides building optimism ...

Investors are rushing to the exits. But why? Let's look into things. The post Why is this ASX 300 stock crashing 18% today?

Walmart's CEO told Trump his tariffs could affect global supply chains and "lead to empty shelves." Does that spell bad news ...

President Donald Trump vowed to impose tariffs on pharmaceuticals within two weeks. Eli Lilly, a leader in the industry, could be harmed by the move, but it is already preparing for it. President ...

Having won FDA approval in early April for its flagship nerve repair product Remplir, Orthocell (ASX:OCC) now has the ...

The White House said on Sunday that it reached a trade deal with China as the two countries negotiated for a second day in ...

How exposed are CSL shares to potential Trump medicinal tariffs? The post Are CSL shares at risk from the Trump tariffs?